Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Int J Rheum Dis. 2017 Nov 3;21(1):20–25. doi: 10.1111/1756-185X.13213

Is Kawasaki Disease an Infectious Disorder?

Anne H Rowley 1
PMCID: PMC5777874  NIHMSID: NIHMS911688  PMID: 29105346

Abstract

Although the etiology of Kawasaki Disease (KD) is largely unknown, a large body of clinical, epidemiologic, immunologic, pathologic and ultrastructural evidence suggests that an infectious agent triggers a cascade that causes the illness. This elusive infectious agent, however, remains unidentified at present. Increasingly sensitive molecular methods for identifying microbial nucleic acids and proteins in tissue samples continue to rapidly emerge, and these methods should be utilized in studies on KD etiology as they become available. Identifying the etiology of this enigmatic diseases remains the single most important research goal in the field, and accomplishing this goal is the best means to improve diagnosis, treatment, and prevention of this potentially fatal childhood disease.

Keywords: Acquired immune response, Cytotoxic T lymphocytes, IgA, Interferon, Oligoclonal antibodies


Kawasaki disease (KD) is the most common medium vessel vasculitis in children. Etiology of this disease is a major pediatric mystery. Among the human vasculitides, KD has features that appear most supportive of an infectious cause. This includes clinical and epidemiologic, pathologic, immunologic, ultrastructural, and transcriptional data. Based upon numerous studies over several decades, however, no known infectious agent causes KD.1

Clinical features

The abrupt onset of high fever in previously healthy children is characteristic of KD and supports acute infection. The clinical findings of conjunctival injection, oral and pharyngeal erythema, cervical adenopathy, and rash are very similar to those observed in other pediatric infections acquired by the respiratory route. The occurrence of self-limited aseptic meningitis, hepatitis, and arthritis in a subset of KD patients supports systemic infection, and the failure of KD patients to respond to antibiotic therapy argues against a bacterial pathogen as an etiologic agent. The self-limited clinical findings and generally non-recurring nature of the febrile illness are highly suggestive of an infection, and not of an autoimmune process.

Epidemiologic features

KD usually affects very young children, mostly those ≤5 years, with peak incidence at 9-11 months of age.2,3 This is a typical peak age for common childhood infections, because it corresponds with the timing of a significant decrease in passive maternal antibodies. The theory that maternal antibody is protective against it, is supported by rarity of KD before 3 months of age. In contrast, autoimmune diseases are quite rare in infants. KD has been associated with epidemics and clusters of illness in countries throughout the world, as would be typical for an infectious etiology.4-8 During a large outbreak in Japan, geographic wave-like spread of illness was clearly demonstrated, typical for an infection spread by the respiratory route.8 In concurrence to increase respiratory infections, KD has a higher incidence in winter-spring.9 The rarity of KD in adults suggests that virtually all adults experienced subclinical infection during childhood and subsequently developed a protective immune response. However, multiple studies over several decades have demonstrated that no known infectious agent can be implicated in KD etiology.10

There is a high prevalence of KD in Asian children, especially in Japan, Korea, China, and Taiwan, strongly supporting the hypothesis that genetic susceptibility determines host response to the KD pathogen(s) and therefore the prevalence of clinical illness. Recent data indicate that ∼1 in 80 Japanese children and ∼1 in 30 Taiwanese children develop KD during early childhood2,11; these very high incidence rates strongly support the hypothesis that a very common (but presently unidentified) infectious agent results in KD and that Asian children are genetically predisposed. The fact that Asian children living a Western lifestyle in the U.S. have the same high incidence rates as those living in Asia supports a genetic predisposition rather than susceptibility based upon cultural practices or geographic location.6

An environmental toxin as the cause of a generally non-recurring disease seems unlikely in the absence of its identification and purposeful removal from the environment. No environmental factors have been consistently associated with KD incidence.5,6,10,12 A recent study investigated association of KD with fine particulate air pollution and found that there was no clear association.13 Other recent studies have reported an apparent association between KD incidence and wind currents.14,15 One theory is that the wind might transmit a fungal toxin that could lead to KD.15 It appears that further clarification of the role of wind-borne transmission in KD etiology will be difficult until the etiologic agent(s) is identified.

A recent interesting study compared epidemiologic patterns of KD and other infectious diseases in children in Japan.16 The authors found that the mean patient age of KD and other viral infections, adjusted for the proportion of the population by age, was significantly negatively correlated with the total fertility rate; i.e. when the fertility rate was higher, the adjusted mean patient age was lower, implying that sibling-to-sibling transmission is likely an important factor in KD incidence. Moreover, these epidemiologic patterns were not consistent with transmission via a novel route such as a transcontinental wind. It was noted that there were significant fluctuations in the number of cases of the infectious diseases studied from year to year, with the exception of KD and exanthema subitum (due to human herpes virus 6 and 7, which are known to result in persistent infection). Substantial year-to year fluctuations would be predicted for infectious diseases with short incubation periods and no persistence of infection. A lack of substantial fluctuations in year-to-year incidence of an infectious disease occurs when the sum of the incubation period and infectious period of these diseases is high, as is observed with persistent infection.16 The authors concluded in this study that the epidemiology of KD points to an etiologic agent transmitted through close contact that remains asymptomatic in most hosts, with an estimated 1% of infections being symptomatic.16

Taken together, these epidemiologic findings best support the hypothesis that KD is caused by a common infectious agent that generally causes an asymptomatic infection, but leads to KD in children with underlying genetic predisposition.

Pathologic features

KD is a multi-systemic inflammatory illness, that particularly affects medium-sized muscular arteries and predominately the coronary arteries. KD arteriopathy is characterized by a three step vasculopathic processes: 1) acute necrotizing arteritis: a neutrophilic process which in the most severe cases results in necrosis of intima and media, leaving only a thin layer of adventitia to support the artery and leading to giant aneurysms, which can rarely rupture; 2) subacute/chronic arteritis: manifested by infiltration of lymphocytes, plasma cells, eosinophils, and macrophages; and, 3) luminal myofibroblastic proliferation: a process by which modified medial smooth muscle cells proliferate and can progressively obstruct the arterial lumen.17 All three processes can be observed in adjacent or non-adjacent segments of the same coronary artery, or can affect different coronary arteries.

A comprehensive study of the pathology of multiple organs and tissues in KD fatalities revealed inflammation in virtually all organ systems.18 This inflammation was non-purulent, and healed without apparent structural damage except in the arterial system. It was noted that inflammation subsided in most tissues by 6-8 weeks after the onset of illness, but persisted after the acute phase in various organs such as lung, spleen, salivary glands, and lymph nodes.18 This was compatible with the possibility of a persistent infectious agent. A high incidence of severe inflammatory lesions in the duct tissues (such as salivary gland duct, bile duct, pancreatic duct, prostatic duct and bronchus) led the authors to conclude that the illness preferentially affects the duct system and the vascular system.18 IgA plasma cells have been shown to be an important component of the vascular and the periductal inflammatory lesions.19,20

These pathological findings, showing significant self-limited inflammatory infiltrates in many organs and tissues, are highly suggestive of a systemic infectious disease, such as a severe viral infection.21,22 The reason for persisting chronic arteritis in a subset of severely affected KD children17 is unclear, but could be due to a persisting infectious agent or to an epitope spreading effect, in which an initial immune response to an infectious agent transitions to target a self-antigen. It should be noted that despite some clinical similarities with KD, the pathologic features of the toxin- and superantigen-mediated illness Staphylococcus aureus toxic shock syndrome differ markedly from KD, and reveal hyaline membranes in the alveoli, acute tubular necrosis of the kidney, and a lack of acute vasculitis.23,24

Immunologic features

The initial neutrophilic predominance in peripheral blood and in KD arterial tissues is compatible with an innate immune response to an acute infection. T lymphocytic (primarily CD8 cell) and IgA plasma cell infiltrates can be identified in acutely inflamed KD coronary arteries, demonstrating robust acquired immune responses and suggesting that they are directed at an intracellular pathogen acquired at a mucosal site such as the respiratory tract.17,19,20,25 Although studies of selective expansion of Vβ2 family T cell receptor expression in acute KD were reported,26,27 suggesting stimulation by a superantigen, this finding was not confirmed in other studies.28,29 B cell receptor sequencing of the IgA response in KD arteries revealed an oligoclonal or antigen-driven B cell response30; sequencing of CD8+ T lymphocytes in peripheral blood of acute KD patients also revealed an oligoclonal CD8+ T cell response.31 These results strongly suggest an acquired immune response to specific antigens in KD children. Synthetic versions of KD oligoclonal antibodies detect antigen in medium-sized ciliated bronchial epithelial cells of KD patients but not infant controls, and also detect antigen in a subset of macrophages in inflamed KD tissues.32-34 The antigen detected by KD synthetic antibodies has not yet been specifically identified, likely because of the difficulty in obtaining the high-quality RNA and proteins from formalin-fixed, paraffin-embedded tissues needed for such identification. However, improved methods for detection of microbial nucleic acid and proteins from these tissues are emerging and should be useful in identifying specific KD antigen(s).35,36 Although acquired B cell responses are prominent in KD tissues, there is no evidence that immune complex deposition occurs or that autoantibodies play a role in disease pathogenesis.19,37,38 Rather, it appears most likely that the oligoclonal B cell and T cell responses are directed at the etiologic agent.

The robust acquired CD8+ T lymphocyte and IgA B lymphocyte immune responses that have been observed in acute KD tissues19,20,25,30,31,33,39 argue against the theory that KD is a primary disorder of innate immunity40 and are highly suggestive of immune response to an infectious agent.

Ultrastructural features

Light and electron microscopy observations show that KD antigen detected by oligoclonal KD antibodies localizes to homogeneous intracytoplasmic inclusion bodies that appear to contain protein and RNA, most closely resembling inclusion bodies formed by viral protein and nucleic acid aggregates.34,41 Ultrastructural studies in KD tissues are limited by the fact that most tissue samples available for research studies are formalin-fixed and paraffin-embedded. However, in three KD lung samples that were formalin-fixed but not paraffin-embedded, ultrastructural morphology was partially preserved, and virus-like particles were observed in close proximity to the inclusion bodies.42

Further investigation of the ultrastructure of the inclusion bodies will require collection of medium-sized ciliated bronchi from acute KD lungs from autopsy and fixation of the tissues in glutaraldehyde, which preserves ultrastructural morphology.43

Transcriptional data

Upregulation of interferon-stimulated gene expression has been observed in acute KD lungs when compared with infant control lungs by real-time reverse transcriptase-PCR,42 strongly suggesting a cellular response to a viral infection. More notably, our recent high throughput RNA sequencing study of KD and control coronary arteries showed features of an antiviral immune response, such as activated cytotoxic T lymphocyte and type I interferon-induced gene upregulation in KD coronary arteries.39 Significantly upregulated interferon-induced genes included IFI30, IFI44, IFI44L, IFIT2, MX1, MX2, OAS1, and OAS2, all of these are known to be induced by viral infection. In contrast, tumor necrosis family α genes were not differentially expressed in KD coronary arteries compared with childhood control coronary arteries.39 Previous studies of the transcriptome of KD peripheral blood showed evidence of neutrophil activation, consistent with neutrophilic leukocytosis during the acute phase, but did not reveal an interferon signature, demonstrating the limitations of peripheral blood transcriptional profiling in delineating gene expression changes in diseased target tissues.44,45

The identification of upregulated interferon-stimulated genes in both KD lung and coronary artery tissues provides additional support for the hypothesis of a viral etiology.

Could KD be caused by any infectious agent in genetically predisposed children?

As etiology of KD has not been elucidated despite various intensive efforts over decades, some investigators have proposed that there is no specific infectious cause of the disease. Instead, they postulate that children with a genetic predisposition can develop KD after experiencing any of a large number of different bacterial and/or viral infections.46 By the very nature of this theory, it is difficult to disprove until a specific causative agent(s) is identified. However, the very distinctive clinical features of KD and the existence of epidemics and clusters of illness argue against this theory. Moreover, if KD is the result of infection with any infectious agent in a predisposed child, recurrences should be common with subsequent infectious triggers, which is not common in KD. The observation that a single synthetic KD monoclonal antibody, derived from IgA plasma cell B cell receptor sequences in KD arterial tissue, binds to ciliated bronchial epithelium in the majority of KD patients but not in infant controls argues for a specific etiologic agent and against the diverse etiologic agent hypothesis.32 Many childhood febrile illnesses with distinctive clinical features, such as polio, roseola, Fifth disease, and other infectious diseases such as acquired immunodeficiency syndrome, were thought to be due to multiple etiologic agents, but later found to be due to a single infectious agent.

Conclusion

The etiology of KD remains one of the major mysteries in the field of Pediatrics, and the lack of this knowledge has hampered improvements in diagnosis and management of this fascinating illness. Moreover, prevention will not be possible until the cause is identified. Researchers should continue to put in efforts in the direction of identification of etiology of KD, which will ultimately enable reductions in the morbidity and mortality from this important childhood illness.

Acknowledgments

This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Disease of the National Institutes of Health under grant number R21AR068041, and the National Institute of Allergy and Infectious Diseases under grant number R56AI106030. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The study was also supported by the Max Goldenberg Foundation and the Center for Kawasaki Disease at the Ann & Robert H. Lurie Children's Hospital of Chicago.

Source of funding: none

Footnotes

Conflicts of interest: none

References

  • 1.Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110(17):2747–71. doi: 10.1161/01.CIR.0000145143.19711.78. [DOI] [PubMed] [Google Scholar]
  • 2.Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J Epidemiol. 2015;25(3):239–45. doi: 10.2188/jea.JE20140089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Holman RC, Belay ED, Christensen KY, Folkema AM, Steiner CA, Schonberger LB. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J. 2010;29(6):483–8. doi: 10.1097/INF.0b013e3181cf8705. [DOI] [PubMed] [Google Scholar]
  • 4.Sano T, Makino N, Aoyama Y, Ae R, Kojo T, Kotani K, et al. Temporal and geographical clustering of Kawasaki disease in Japan: 2007-2012. Pediatr Int. 2016;58(11):1140–5. doi: 10.1111/ped.12970. [DOI] [PubMed] [Google Scholar]
  • 5.Bell DM, Brink EW, Nitzkin JL, Hall CB, Wulff H, Berkowitz ID, et al. Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med. 1981;304(26):1568–75. doi: 10.1056/NEJM198106253042603. [DOI] [PubMed] [Google Scholar]
  • 6.Dean AG, Melish ME, Hicks R, Palumbo NE. An epidemic of Kawasaki syndrome in Hawaii. J Pediatr. 1982;100(4):552–7. doi: 10.1016/S0022-3476(82)80751-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Salo E, Pelkonen P, Pettay O. Outbreak of Kawasaki syndrome in Finland. Acta Paediatr Scand. 1986;75(1):75–80. doi: 10.1111/j.1651-2227.1986.tb10160.x. [DOI] [PubMed] [Google Scholar]
  • 8.Yanagawa H, Nakamura Y, Kawasaki T, Shigematsu I. Nationwide epidemic of Kawasaki disease in Japan during winter of 1985-86. Lancet. 1986;2(8516):1138–9. doi: 10.1016/s0140-6736(86)90541-6. [DOI] [PubMed] [Google Scholar]
  • 9.Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 2012;22(2):79–85. doi: 10.2188/jea.JE20110131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rowley AH, Baker SC, Orenstein JM, Shulman ST. Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight. Nat Rev Microbiol. 2008;6(5):394–401. doi: 10.1038/nrmicro1853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Wu MH, Lin MT, Chen HC, Kao FY, Huang SK. Postnatal Risk of Acquiring Kawasaki Disease: A Nationwide Birth Cohort Database Study. J Pediatr. 2017;180:80–86. doi: 10.1016/j.jpeds.2016.09.052. [DOI] [PubMed] [Google Scholar]
  • 12.Rowley AH, Shulman ST. The search for the etiology of Kawasaki disease. Pediatr Infect Dis J. 1987;6(6):506–8. doi: 10.1097/00006454-198706000-00002. [DOI] [PubMed] [Google Scholar]
  • 13.Zeft AS, Burns JC, Yeung RS, McCrindle BW, Newburger JW, Dominguez SR, et al. Kawasaki Disease and Exposure to Fine Particulate Air Pollution. J Pediatr. 2016;177:179–83 e1. doi: 10.1016/j.jpeds.2016.06.061. [DOI] [PubMed] [Google Scholar]
  • 14.Rodo X, Ballester J, Cayan D, Melish ME, Nakamura Y, Uehara R, et al. Association of Kawasaki disease with tropospheric wind patterns. Scientific reports. 2011;1:152. doi: 10.1038/srep00152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Rodo X, Curcoll R, Robinson M, Ballester J, Burns JC, Cayan DR, et al. Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan. Proc Natl Acad Sci U S A. 2014;111(22):7952–7. doi: 10.1073/pnas.1400380111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Nagao Y, Urabe C, Nakamura H, Hatano N. Predicting the characteristics of the aetiological agent for Kawasaki disease from other paediatric infectious diseases in Japan. Epidemiol Infect. 2016;144(3):478–92. doi: 10.1017/S0950268815001223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Orenstein JM, Shulman ST, Fox LM, Baker SC, Takahashi M, Bhatti TR, et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS ONE. 2012;7(6):e38998. doi: 10.1371/journal.pone.0038998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Amano S, Hazama F, Kubagawa H, Tasaka K, Haebara H, Hamashima Y. General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn. 1980;30(5):681–94. [PubMed] [Google Scholar]
  • 19.Rowley AH, Eckerley CA, Jack HM, Shulman ST, Baker SC. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol. 1997;159(12):5946–55. [PubMed] [Google Scholar]
  • 20.Rowley AH, Shulman ST, Mask CA, Finn LS, Terai M, Baker SC, et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis. 2000;182(4):1183–91. doi: 10.1086/315832. [DOI] [PubMed] [Google Scholar]
  • 21.Rubin S, Eckhaus M, Rennick LJ, Bamford CG, Duprex WP. Molecular biology, pathogenesis and pathology of mumps virus. J Pathol. 2015;235(2):242–52. doi: 10.1002/path.4445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Guarner J, Paddock CD, Shieh WJ, Packard MM, Patel M, Montague JL, et al. Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. Clin Infect Dis. 2006;43(2):132–40. doi: 10.1086/505122. [DOI] [PubMed] [Google Scholar]
  • 23.Larkin SM, Williams DN, Osterholm MT, Tofte RW, Posalaky Z. Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases. Ann Intern Med. 1982;96(6 Pt 2):858–64. doi: 10.7326/0003-4819-96-6-858. [DOI] [PubMed] [Google Scholar]
  • 24.Paris AL, Herwaldt LA, Blum D, Schmid GP, Shands KN, Broome CV. Pathologic findings in twelve fatal cases of toxic shock syndrome. Ann Intern Med. 1982;96(6 Pt 2):852–7. doi: 10.7326/0003-4819-96-6-852. [DOI] [PubMed] [Google Scholar]
  • 25.Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis. 2001;184(7):940–3. doi: 10.1086/323155. [DOI] [PubMed] [Google Scholar]
  • 26.Abe J, Kotzin BL, Meissner C, Melish ME, Takahashi M, Fulton D, et al. Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med. 1993;177(3):791–6. doi: 10.1084/jem.177.3.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Yoshioka T, Matsutani T, Iwagami S, Toyosaki-Maeda T, Yutsudo T, Tsuruta Y, et al. Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease. Immunology. 1999;96(3):465–72. doi: 10.1046/j.1365-2567.1999.00695.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Pietra BA, De Inocencio J, Giannini EH, Hirsch R. TCR V beta family repertoire and T cell activation markers in Kawasaki disease. J Immunol. 1994;153(4):1881–8. [PubMed] [Google Scholar]
  • 29.Mancia L, Wahlstrom J, Schiller B, Chini L, Elinder G, D'Argenio P, et al. Characterization of the T-cell receptor V-beta repertoire in Kawasaki disease. Scand J Immunol. 1998;48(4):443–9. doi: 10.1046/j.1365-3083.1998.00415.x. [DOI] [PubMed] [Google Scholar]
  • 30.Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol. 2001;166(2):1334–43. doi: 10.4049/jimmunol.166.2.1334. [DOI] [PubMed] [Google Scholar]
  • 31.Choi IH, Chwae YJ, Shim WS, Kim DS, Kwon DH, Kim JD, et al. Clonal expansion of CD8+ T cells in Kawasaki disease. J Immunol. 1997;159(1):481–6. [PubMed] [Google Scholar]
  • 32.Rowley AH, Baker SC, Shulman ST, Garcia FL, Guzman-Cottrill JA, Chou P, et al. Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. J Infect Dis. 2004;190(4):856–65. doi: 10.1086/422648. [DOI] [PubMed] [Google Scholar]
  • 33.Rowley AH, Shulman ST, Garcia FL, Guzman-Cottrill JA, Miura M, Lee HL, et al. Cloning the arterial IgA antibody response during acute Kawasaki disease. J Immunol. 2005;175(12):8386–91. doi: 10.4049/jimmunol.175.12.8386. [DOI] [PubMed] [Google Scholar]
  • 34.Rowley AH, Baker SC, Shulman ST, Garcia FL, Fox LM, Kos IM, et al. RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS ONE. 2008;3(2):e1582. doi: 10.1371/journal.pone.0001582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Gustafsson OJ, Arentz G, Hoffmann P. Proteomic developments in the analysis of formalin-fixed tissue. Biochim Biophys Acta. 2015;1854(6):559–80. doi: 10.1016/j.bbapap.2014.10.003. [DOI] [PubMed] [Google Scholar]
  • 36.Bodewes R, van Run PR, Schurch AC, Koopmans MP, Osterhaus AD, Baumgartner W, et al. Virus characterization and discovery in formalin-fixed paraffin-embedded tissues. J Virol Methods. 2015;214:54–9. doi: 10.1016/j.jviromet.2015.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Nash MC, Shah V, Reader JA, Dillon MJ. Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies are not increased in Kawasaki disease. Br J Rheumatol. 1995;34(9):882–7. doi: 10.1093/rheumatology/34.9.882. [DOI] [PubMed] [Google Scholar]
  • 38.Lee LA, Burns J, Glode M, Harmon C, Weston WL. No autoantibodies to nuclear antigens in the Kawasaki syndrome. N Engl J Med. 1983;308(17):1034. doi: 10.1056/NEJM198304283081718. [DOI] [PubMed] [Google Scholar]
  • 39.Rowley AH, Wylie KM, Kim KY, Pink AJ, Yang A, Reindel R, et al. The transcriptional profile of coronary arteritis in Kawasaki disease. BMC Genomics. 2015;16(1):1076. doi: 10.1186/s12864-015-2323-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Hara T, Nakashima Y, Sakai Y, Nishio H, Motomura Y, Yamasaki S. Kawasaki disease: a matter of innate immunity. Clin Exp Immunol. 2016;186(2):134–43. doi: 10.1111/cei.12832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Rowley AH, Baker SC, Shulman ST, Fox LM, Takahashi K, Garcia FL, et al. Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. J Infect Dis. 2005;192(10):1757–66. doi: 10.1086/497171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Rowley AH, Baker SC, Shulman ST, Rand KH, Tretiakova MS, Perlman EJ, et al. Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a “new” virus associated with Kawasaki disease. J Infect Dis. 2011;203(7):1021–30. doi: 10.1093/infdis/jiq136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Rowley AH. Finding the cause of Kawasaki disease: a pediatric infectious diseases research priority. J Infect Dis. 2006;194(12):1635–7. doi: 10.1086/509514. [DOI] [PubMed] [Google Scholar]
  • 44.Popper SJ, Shimizu C, Shike H, Kanegaye JT, Newburger JW, Sundel RP, et al. Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol. 2007;8(12):R261. doi: 10.1186/gb-2007-8-12-r261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Popper SJ, Watson VE, Shimizu C, Kanegaye JT, Burns JC, Relman DA. Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection. J Infect Dis. 2009;200(4):657–66. doi: 10.1086/603538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Cohen E, Sundel R. Kawasaki Disease at 50 Years. JAMA Pediatr. 2016;170(11):1093–9. doi: 10.1001/jamapediatrics.2016.1446. [DOI] [PubMed] [Google Scholar]

RESOURCES